发明名称 |
BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |
摘要 |
The invention relates to a method for predicting the clinical response to a therapy based on the administration of mesenchymal stem cells (MSCs) in a patient suffering from an immune-mediated inflammatory disease. The invention also relates to methods of personalised medicine as well as to therapeutic uses of MSCs in a patient suffering from an immune-mediated inflammatory disease. |
申请公布号 |
WO2016170187(A3) |
申请公布日期 |
2016.12.01 |
申请号 |
WO2016EP59196 |
申请日期 |
2016.04.25 |
申请人 |
TIGENIX, S.A.U |
发明人 |
DE LA ROSA, Olga;DALEMANS, Wilfried |
分类号 |
G01N33/50;A61K35/28 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|